Collaboration - October 20, 2021
BioLamina with partners receive funding of 40 million SEK
BioLamina with partners in the innovation milieu IndiCell receive funding to establish and propel individualized cell therapy treatments in Sweden. The funded project focuses on an autologous therapy model, in which skin cells are harvested from the patients themselves, then carefully reprogrammed into induced pluripotent stem (iPS) cells in the laboratory, and finally returned to […]
Agreement - September 16, 2014
BioLamina enters agreement with Corning
Corning Incorporated has entered into an agreement with BioLamina to manufacture and package the Recombinant Laminin-521 (rLaminin-521) pluripotent stem-cell and neural stem-cell growth matrix. “As cell-culture and cell-therapy technologies progress, it is increasingly important to offer today’s researchers more powerful and reliable culture systems,” said Kristian Tryggvason, Ph.D., CEO, BioLamina. “Through this agreement with Corning, […]
Collaboration - November 13, 2013
Vitrolife and Biolamina increase collaboration
The companies have decided to increase their collaboration and, as part of this greater collaboration, Vitrolife has invested in Biolamina together with the company’s present owners. Vitrolife has collaborated with the Stockholm-based Biolamina within the stem-cell field since 2012. During spring the collaboration resulted in the launch of a new freeze medium for stem cells, […]
Biotech Business - March 27, 2013
Roche and BioLamina start collaboration
Stockholm-based BioLamina recently signed a new R&D agreement with Roche to develop novel cell culture systems. The systems will be aimed at various applications, including stem cell research. BioLamina’s and Roche’s collaboration will focus on assessing laminin-based in-vitro cell culture matrices offering highly physiological microenvironments for living cells. According to BioLamina, laminins are proteins located […]
